Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 10 AMLX Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
May 10 AMLX Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
May 10 AMPH Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
May 10 AMLX Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
May 10 ALPN Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
May 10 ALPN Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires
May 10 ABBV Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
May 10 ABBV 3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
May 10 AMPH Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
May 10 ACRS Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
May 9 ALPN Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.12, revenue of $7.03M beats by $3.51M
May 9 AMPH Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
May 9 ALPN Alpine Immune Sciences Reports First Quarter 2024 Financial Results
May 9 AMPH Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
May 9 AMLX Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2024 Earnings Call Transcript
May 9 AMLX Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
May 9 AMPH Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
May 9 AMLX Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M
May 9 ABBV Q1 2024 Regenxbio Inc Earnings Call
May 9 AMLX Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags